CLINICAL TRIALS PROFILE FOR PATANOL
✉ Email this page to a colleague
All Clinical Trials for PATANOL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00609128 ↗ | Effect of Olopatadine on Allergic Tear Mediators | Completed | National Eye Institute (NEI) | N/A | 2000-09-01 | The purpose of the research is to determine which inflammatory substances are involved in causing allergic symptoms in the eye. Allergic conjunctivitis is a common problem with symptoms of temporary redness, itching, tearing, and swelling of the eyes. Substances released by cells in the affected tissues cause allergic reactions in the eye and elsewhere in the body. |
NCT00609128 ↗ | Effect of Olopatadine on Allergic Tear Mediators | Completed | University of Wisconsin, Madison | N/A | 2000-09-01 | The purpose of the research is to determine which inflammatory substances are involved in causing allergic symptoms in the eye. Allergic conjunctivitis is a common problem with symptoms of temporary redness, itching, tearing, and swelling of the eyes. Substances released by cells in the affected tissues cause allergic reactions in the eye and elsewhere in the body. |
NCT01119287 ↗ | Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis | Completed | Alcon Research | Phase 4 | 2010-03-01 | The purpose of this study was to evaluate the efficacy of Maxidex and Patanol compared to placebo in patients with allergic conjunctivitis when exposed to controlled allergen levels in an Environmental Exposure Chamber (EEC). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PATANOL
Condition Name
Clinical Trial Locations for PATANOL
Trials by Country
Clinical Trial Progress for PATANOL
Clinical Trial Phase
Clinical Trial Sponsors for PATANOL
Sponsor Name